| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| R&D Expense | $5.2M | — | -55.2% |
| SG&A Expense | $1.1M | — | -44.7% |
| Operating Income | -$6.3M | — | +53.7% |
| Pre-tax Income | -$5.5M | — | +49.7% |
| Income Tax | $49K | — | +69.0% |
| Net Income | -$5.5M | — | +49.4% |
| EPS (Basic) | -$0.18 | — | +50.0% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $115.5M | -8.0% | -25.9% |
| Current Assets | $117.0M | -7.8% | -25.8% |
| Total Assets | $139.8M | -6.8% | -23.1% |
| Current Liabilities | $3.0M | -62.2% | -44.6% |
| Total Liabilities | $4.8M | -50.5% | -32.6% |
| Stockholders' Equity | $135.0M |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$9.0M | — | -33.5% |
| Capital Expenditures | $0 | — | -100.0% |
| Investing Cash Flow | $9K | — | +109.6% |
| Financing Cash Flow | $0 | — | +100.0% |
| Free Cash Flow | -$9.0M | — | -31.6% |
| -22.7% |